Cyclooxygenase-2 selective inhibitors, compositions and...

Details Cyclooxygenase-2 selective inhibitors, compositions and... Cyclooxygenase-2 selective inhibitors, compositions and...

2006-05-05

2008-10-28

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S406000

Reexamination Certificate

active

07442802

ABSTRACT:
The invention describes novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one COX-2 selective inhibitor, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

REFERENCES:
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5536752 (1996-07-01), Ducharme et al.
patent: 5550142 (1996-08-01), Ducharme et al.
patent: 5633272 (1997-05-01), Talley et al.
patent: 5710140 (1998-01-01), Ducharme et al.
patent: 5719163 (1998-02-01), Norman et al.
patent: 5859257 (1999-01-01), Talley
patent: 5945539 (1999-08-01), Haruta et al.
patent: 5985902 (1999-11-01), Talley et al.
patent: 5994381 (1999-11-01), Haruta et al.
patent: 6002014 (1999-12-01), Haruta et al.
patent: 6040341 (2000-03-01), Del Soldato et al.
patent: 6297260 (2001-10-01), Bandarage et al.
patent: 6436967 (2002-08-01), Talley et al.
patent: 6482956 (2002-11-01), Luengo et al.
patent: 6362209 (2003-03-01), Haruta et al.
patent: 6649629 (2003-11-01), Bandarage et al.
patent: 6673818 (2004-01-01), Brown et al.
patent: 6699884 (2004-03-01), Brown et al.
patent: 7211598 (2007-05-01), Garvey et al.
patent: 2004/0006133 (2004-01-01), Ranatunge et al.
patent: 2004/0072883 (2004-04-01), Garvey et al.
patent: 2004/0082652 (2004-04-01), Del Soldato et al.
patent: 2005/0032851 (2005-02-01), Talley et al.
patent: 2005/0032852 (2005-02-01), Carter
patent: 2005/0101661 (2005-05-01), Del Soldato et al.
patent: WO 95/15316 (1995-06-01), None
patent: WO 95/18799 (1995-07-01), None
patent: WO 96/25405 (1996-08-01), None
patent: WO 96/36617 (1996-11-01), None
patent: WO 97/38986 (1997-10-01), None
patent: WO 00/25776 (2000-05-01), None
patent: WO 01/45703 (2001-06-01), None
patent: WO 04/000300 (2003-12-01), None
patent: WO 04/000781 (2003-12-01), None
patent: WO 2004/024186 (2004-03-01), None
patent: WO 2005/030224 (2005-04-01), None
Jul. 11, 2005. Supplementary European Search Report for European Patent Application No. 03762000.2.
Jun. 9, 2004. International Search Report from PCT/US03/19850.

Affiliated with

Also associated with

Rating

Cyclooxygenase-2 selective inhibitors, compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclooxygenase-2 selective inhibitors, compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclooxygenase-2 selective inhibitors, compositions and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4014139